Senna Plus
NDC Package 66424-378-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Senna Plus is take preferably at bedtime or as directed by a doctoragestarting dosagemaximum dosageAdults and children 12 years and over2 tablets once a day 4 tablets twice a dayChildren 6 to under 12 years1 tablet once a day2 tablets  twice a dayChildren 2 to under 6 years 1/2 tablet  once a day1 tablet twice a dayChildren under 2 yearsask a doctorask a  doctor. Marketed by Sda Laboratories, Inc., this product is identified by NDC 66424-378 and is authorized under FDA application part334.

Identification & Billing

NDC Package Code
66424-378-02
Package Description
120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
Product Code
66424-378
11-Digit Billing Format
66424037802
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Senna Plus
Dosage Form
-
Usage Information
Take preferably at bedtime or as directed by a doctoragestarting dosagemaximum dosageAdults and children 12 years and over2 tablets once a day 4 tablets twice a dayChildren 6 to under 12 years1 tablet once a day2 tablets  twice a dayChildren 2 to under 6 years 1/2 tablet  once a day1 tablet twice a dayChildren under 2 yearsask a doctorask a  doctor

Regulatory & Marketing

Labeler Name
Sda Laboratories, Inc.
FDA Application #
part334
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
04-15-2019
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66424-378-02 identifies a specific commercial package of 120 tablet, film coated in 1 bottle, plastic of Senna Plus, labeled by Sda Laboratories, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sda Laboratories, Inc. on April 15, 2019. The current certification is valid through December 31, 2021.

How is this Sda Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66424037802. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66424-378-02
11-Digit CMS (5-4-2)
66424-0378-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.